Renal tubular acidosis (RTA) is hyperchloremic metabolic acidosis from impaired renal acid-base handling with normal anion gap. Type 1 RTA (distal) results from proximal tubule inability to reabsorb filtered bicarbonate or from collecting duct inability to secrete hydrogen ions, causing high urine pH despite systemic acidosis. Type 2 RTA (proximal) results from reduced proximal tubule bicarbonate reabsorption from impaired carbonic anhydrase or mitochondrial dysfunction. Type 4 RTA results from aldosterone deficiency or resistance, causing both hyperkalemia and acidosis.
Use urine anion gap and urine osmolar gap to identify Type 1 RTA (positive anion gap, high urine pH). Study specific causes: Type 1 from amphotericin B, Type 2 from carbonic anhydrase inhibitors, Type 4 from ACE inhibitors. Understand the bone loss from chronic acidosis.
RTA does not cause hyperkalemia except in Type 4; Types 1 and 2 cause hypokalemia from increased urinary losses. Type 1 RTA cannot lower urine pH below 5.5 (specific acid secretion defect), while in Type 2 RTA, urine pH falls normally if systemic pH is corrected. Hypokalemia in Type 1 RTA worsens alkaline urine by promoting bicarbonate reabsorption.
From your work on metabolic acidosis and alkalosis, you know that the kidneys are the long-term regulators of pH — they reclaim bicarbonate filtered at the glomerulus and generate new bicarbonate by excreting acid in the urine. Renal tubular acidosis is what happens when this machinery fails, but fails in a very specific way: the anion gap stays normal. This is your first diagnostic clue. Normal anion gap metabolic acidosis means the body is losing bicarbonate or failing to regenerate it, but organic acids are not accumulating — the chloride rises proportionally to fill the gap left by the lost bicarbonate. RTA is characterized by hyperchloremic, normal anion gap metabolic acidosis, and each type has a distinct defect in a different part of the nephron.
Type 1 (Distal) RTA is a defect in the collecting duct's ability to secrete hydrogen ions against a concentration gradient. Normally, H⁺-ATPase pumps in intercalated cells drive urine pH below 5.5, generating the acidic urine needed to eliminate the daily acid load. In Type 1 RTA, this pump is absent, impaired, or backleak occurs across a leaky tubule membrane, so urine pH remains above 5.5 even during systemic acidosis — a paradox that is diagnostically definitive. The bicarbonate that should be regenerated is instead lost, and serum bicarbonate falls progressively. Because the distal tubule's failure to secrete H⁺ disrupts the normal electrochemical gradient that also drives potassium reabsorption, patients waste potassium in urine and develop hypokalemia. Chronic acidosis also dissolves bone (as carbonate buffers H⁺) and raises urinary calcium, causing nephrolithiasis and nephrocalcinosis.
Type 2 (Proximal) RTA is a different defect: the proximal tubule cannot reabsorb the enormous filtered bicarbonate load (80–85% of bicarbonate is normally reclaimed here). When bicarbonate exceeds the tubule's reabsorption threshold, it spills into urine, dragging sodium and potassium with it — explaining the hypokalemia. The distinguishing feature is that once the serum bicarbonate falls low enough that the filtered load is within the impaired tubule's reduced capacity, the urine pH normalizes and stops falling further. So in Type 2, urine pH is high when bicarb is high and normal when bicarb is low — the opposite temporal pattern from Type 1. Type 2 is classically associated with Fanconi syndrome (global proximal tubule dysfunction losing glucose, amino acids, phosphate, and uric acid as well as bicarbonate) and with carbonic anhydrase inhibition.
Type 4 RTA is mechanistically distinct: it results from aldosterone deficiency or resistance. Aldosterone normally drives the principal cells of the collecting duct to retain sodium and secrete both potassium and hydrogen. Without aldosterone effect, both K⁺ and H⁺ accumulate in blood — producing the unique combination of hyperkalemia and metabolic acidosis that identifies Type 4. The hyperkalemia itself worsens the acidosis because elevated K⁺ shifts intracellularly while H⁺ shifts out (to maintain electroneutrality), and high K⁺ inhibits renal ammonia synthesis, reducing the kidney's capacity to buffer and excrete acid. Type 4 is the most common RTA in clinical practice and is commonly caused by diabetic nephropathy (hyporeninemic hypoaldosteronism) or ACE inhibitors reducing angiotensin II-driven aldosterone secretion.
No topics depend on this one yet.